Cargando…

Cost-Effectiveness of Buprenorphine and Naltrexone Treatments for Heroin Dependence in Malaysia

AIMS: To aid public health policymaking, we studied the cost-effectiveness of buprenorphine, naltrexone, and placebo interventions for heroin dependence in Malaysia. DESIGN: We estimated the cost-effectiveness ratios of three treatments for heroin dependence. We used a microcosting methodology to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruger, Jennifer Prah, Chawarski, Marek, Mazlan, Mahmud, Ng, Nora, Schottenfeld, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514172/ https://www.ncbi.nlm.nih.gov/pubmed/23226534 http://dx.doi.org/10.1371/journal.pone.0050673

Ejemplares similares

Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients
por: Moore, Brent A., et al.
Publicado: (2007)

Naltrexone as a Treatment for Heroin Dependence and its relationship with Depression
por: Kak, Insha Mehraj, et al.
Publicado: (2022)

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment
por: Barry, Declan T., et al.
Publicado: (2007)

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence
por: Wang, A-L, et al.
Publicado: (2015)

Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment
por: Yee, Anne, et al.
Publicado: (2016)

A Comparison of the Efficacy of Buprenorphine and Clonidine in Detoxification of Heroin-Dependents and the Following Maintenance Treatment
por: Ziaaddini, Hassan, et al.
Publicado: (2010)

Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients
por: Zaaijer, Eline R., et al.
Publicado: (2015)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail
por: Velasquez, Melissa, et al.
Publicado: (2019)

The Effects of Maternally Administered Methadone, Buprenorphine and Naltrexone on Offspring: Review of Human and Animal Data
por: Farid, W.O, et al.
Publicado: (2008)

Retrospective analysis of heroin detoxification with buprenorphine in a psychiatric hospital in Japan
por: Nagano, Tatsushi, et al.
Publicado: (2020)

Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
por: Nguyen, Thuy, et al.
Publicado: (2022)

Naltrexone and the Treatment of Alcohol Dependence
por: Volpicelli, Joseph R., et al.
Publicado: (1994)

Buprenorphine is a weak dopamine releaser relative to heroin, but its pretreatment attenuates heroin‐evoked dopamine release in rats
por: Isaacs, Dominic P., et al.
Publicado: (2020)

Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco
por: Carter, Jamie, et al.
Publicado: (2019)

A Retrospective Survey of Buprenorphine Substitute Treatment With Minimal Dosage in Heroin Use Disorder
por: Shen, Wenwen, et al.
Publicado: (2019)

Micro-costing in health and medicine: a critical appraisal
por: Xu, Xiao, et al.
Publicado: (2021)

Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
por: Szczesniak, Laura M., et al.
Publicado: (2020)

A Prospective Three-Months Naturalistic Follow-Up Study of Outcomes of Patients with Opioid Dependence Discharged on Buprenorphine or Oral Naltrexone
por: Singh, Virendra Vikram, et al.
Publicado: (2022)

Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts?
por: Maremmani, Angelo Giovanni Icro, et al.
Publicado: (2011)

Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood
por: Leventelis, Christonikos, et al.
Publicado: (2019)

Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence
por: Ramdurg, Santosh, et al.
Publicado: (2015)

Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
por: Kunøe, Nikolaj, et al.
Publicado: (2016)

Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy
por: Pajusco, Benedetta, et al.
Publicado: (2012)

Micro-costing studies in the health and medical literature: protocol for a systematic review
por: Xu, Xiao, et al.
Publicado: (2014)

An Alternative Framework for Analyzing Financial Protection in Health
por: Ruger, Jennifer Prah
Publicado: (2012)

Health and social justice
por: Ruger, Jennifer Prah
Publicado: (2004)

The injustice of COVID-19: we need a moral constitution for our planet's health
por: Ruger, Jennifer Prah
Publicado: (2020)

Social justice as a foundation for democracy and health
por: Ruger, Jennifer Prah
Publicado: (2020)

Buprenorphine Outpatient Outcomes Project: can Suboxone be a viable outpatient option for heroin addiction?
por: Sittambalam, Charmian D., et al.
Publicado: (2014)

Cost-Effectiveness of Peer-Delivered Interventions for Cocaine and Alcohol Abuse among Women: A Randomized Controlled Trial
por: Prah Ruger, Jennifer, et al.
Publicado: (2012)

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations
por: Cook, R. R., et al.
Publicado: (2023)

Correction: Cost-Effectiveness of Peer-Delivered Interventions for Cocaine and Alcohol Abuse among Women: A Randomized Controlled Trial
por: Ruger, Jennifer Prah, et al.
Publicado: (2012)

Naltrexone long-acting formulation in the treatment of alcohol dependence
por: Johnson, Bankole A
Publicado: (2007)

Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting
por: Mannelli, Paolo, et al.
Publicado: (2022)

Barriers and Facilitators to Clinician Readiness to Provide Emergency Department–Initiated Buprenorphine
por: Hawk, Kathryn F., et al.
Publicado: (2020)

Naltrexone/Bupropion: Contrave®; Naltrexone SR/Bupropion SR
Publicado: (2012)

A Checklist for the Conduct, Reporting, and Appraisal of Microcosting Studies in Health Care: Protocol Development
por: Ruger, Jennifer Prah, et al.
Publicado: (2016)

Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women
por: Ruger, Jennifer Prah, et al.
Publicado: (2009)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
por: Mannelli, Paolo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l4vrk8ep96dot7jilonb420f59